Bioxytran, Inc.
BIXT
$0.1567
-$0.0054-3.33%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.20K | 34.70K | 13.50K | 10.00K | 26.10K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 5.20K | 34.70K | 13.50K | 10.00K | 26.10K |
|
|
|||||
| Total Current Assets | 5.20K | 34.70K | 13.50K | 10.00K | 26.10K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 133.50K | 124.30K | 115.00K | 115.50K | 113.30K |
| Total Assets | 138.70K | 159.00K | 128.60K | 125.50K | 139.40K |
|
|
|||||
| Total Accounts Payable | 147.60K | -- | 2.70K | 700.00 | 3.70K |
| Total Accrued Expenses | 277.90K | 259.80K | 321.60K | 98.40K | 301.00K |
| Short-term Debt | 1.09M | 933.60K | 839.00K | 972.60K | 1.93M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 411.00K | 50.20K | 65.20K | 44.20K | 1.01M |
| Total Other Current Liabilities | 411.00K | 50.20K | 65.20K | 44.20K | 1.01M |
| Total Current Liabilities | 1.93M | 1.24M | 1.23M | 1.12M | 3.24M |
|
|
|||||
| Total Current Liabilities | 1.93M | 1.24M | 1.23M | 1.12M | 3.24M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.09M | 933.60K | 839.00K | 972.60K | 1.93M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.93M | 1.24M | 1.23M | 1.12M | 3.24M |
|
|
|||||
| Common Stock & APIC | 17.09M | 17.29M | 16.55M | 16.00M | 13.23M |
| Retained Earnings | -18.92M | -18.40M | -16.96M | -16.30M | -15.70M |
| Treasury Stock & Other | -- | -- | -- | -- | 45.00K |
| Total Common Equity | -1.84M | -1.11M | -405.70K | -296.20K | -2.42M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 43.20K | 28.90K | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 43.20K | 28.90K | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.84M | -1.11M | -405.70K | -296.20K | -2.42M |
| Total Preferred Equity | 43.20K | 28.90K | -- | -- | -- |
| Total Minority Interest | -- | -- | -694.20K | -694.20K | -680.90K |
| Total Equity | -1.79M | -1.08M | -1.10M | -990.40K | -3.10M |
|
|
|||||